About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

SFGT for Persistent Anxiety and Depression | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05942495

SFGT for Persistent Anxiety and Depression

Rationale: Although there are effective treatments available for anxiety and depression, there is a large group of clients that does not benefit sufficiently from first-choice treatment. For this grou...

Lead sponsor: GGZ Noord-Holland-Noord•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

GGZ Noord-Holland-Noord

Study design: A Single Case Experimental Design (SCED), using repeated measures over four different phases.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Persistent anxiety or depression symptoms (at least moderate score at the subscale depression (≥7 or anxiety ≥6 on the DASS-21).
•* History of at least one previous evidence-based therapy focused on anxiety, depression or PTSD according to the Dutch national guidelines.
•* Able to comprehend Dutch at a level sufficient to complete self-report.

Exclusion Criteria

•Clients with severe problems that need to be addressed first, including substance abuse, psychosis, anxiety disorder, PTSD or depression that not have been treated.
•* Start of (or change in) medication which is not yet stabilized at the start of this study.
•* Psychosocial problems such as homelessness, no income or high debts which would make the clients unable to participate in a group.

Related studies

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

NCT05569018 · Anxiety Disorders, Depressive Disorders

The Impact of Melatonin Lotion on Sleep and Mental Health

NCT06768749 · Sleep Problems, Depressive Disorder and Anxiety Disorders

Activating Social Resources in Psychotherapy-Seeking Individuals: Effectiveness and Timing of a Social Support Just-in-Time Adaptive Intervention

NCT07471529 · Loneliness, Social Support, and more

DINO RCT - Treating Anxiety in Children With Autism

NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders

High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

NCT06968026 · Recurrent Pregnancy Loss, Anxiety Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 12, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment15

Start dateJul 2023

Last updatedMar 12, 2025

Condition

Depressive Symptoms Anxiety Disorders Persistent Anxiety Depression

Locations shown

Stichting GGZ Noord-Holland-Noord

Heerhugowaard, North Holland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions